Braxia Scientific CEO Dr. Roger McIntyre to Join Advisory Board of At-Home Telemedicine Platform KetaMD
- Tuesday, November 9, 2021, 7:01
- Finance
- Add a comment
TORONTO, Nov. 9, 2021 /PRNewswire/ – Braxia Scientific Corp. (“Braxia”, or the “Company”), (CSE: BRAX) (OTC: BRAXF) (FWB: 496), a medical research company with clinics providing innovative ketamine treatments for persons with depression and related disorders, is delighted to announce that…
About the Author
adminasapcorp has written 41555 stories on this site.